Relugolix - New 0ral Gonadotropin-Releasing Hormone (GnRH) Antagonist

Atsushi Imai, Hazuki Kagawa, Satoshi Ichigo, Hiroshi Takagi, Kazutoshi Matsunami and Masashi Hori
Additional contact information
Masashi Hori: Department of Obstetrics and Gynecology, Matsunami General Hospital, Japan

Biomedical Journal of Scientific & Technical Research, 2019, vol. 18, issue 3, 13675-13676

Abstract: With the recent development of Gonadotropin-Releasing Hormone (GnRH) analogs, physicians have manipulated gonadotropin secretion and, consequently, to treat sex steroid-dependent hormonal disorders such as central precocious puberty...

Keywords: Biomedical Sciences; Biomedical Research; Technical Research; Gonadotropin-Releasing Hormone Antagonist; Orally Active Nonpeptide Formula; Uterine Myoma; Dysfunctional Uterine Bleeding; Hormone-Dependent Disorder (search for similar items in EconPapers)
Date: 2019
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.003169.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.003169.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:18:y:2019:i:3:p:13675-13676

DOI: 10.26717/BJSTR.2019.18.003169

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().